Consistently, a recent study showed that deletion of endothelial ZEB1 in tumor-bearing mice reduced tumor angiogenesis and led to sustained normalization of tumor vasculature by epigenetically repressing TGF-β signaling (Fu et al., 2020). The gene discussed is TGFB1; the disease is neoplasm.